Article
The Role of OSM/OSMRβ Axis in Chronic Liver Disease Progression and Hepatocellular Carcinoma Development: A Focus on MASLD/MASH
2026-08-11
Abstract excerpt
Metabolic dysfunction – Associated Steatotic Liver Disease (MASLD) represents the emerging leading cause of Chronic Liver Disease (CLD) worldwide, with a global prevalence of approx. 30% in the general population that parallels global rates of obesity and Type 2 Diabetes (T2D). At present no validated therapy is available to block or slow down disease progression to Metabolic dysfunction – Associated SteatoHepatit...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 84627510-8a73-5775-95ec-6eba36e0ee9b
- DOI
- 10.20944/preprints202608.0645.v1
